Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Kenmure

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
British Heart Journal|February 1, 1987
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxideN S Chan, J McLay, A C Kenmure
British Medical Journal|June 3, 1978
Cardiac signs for students: the wheat and the chaffJ K Finlayson, A C Kenmure, D S Short
American Heart Journal|February 1, 1972
A four-year review of cardiac pacing in Glasgow: 181 Medtronic generators implanted in 127 patientsG D Green, W Forbes, G B Shaw, et al.
Journal of Applied Physiology|February 1, 1972
Hemodynamic effects of oxygen at 1 and 2 Ata pressure in healthy subjectsA C Kenmure, W R Murdoch, I Hutton, et al.
Scottish Medical Journal|February 1, 1993
Coronary artery ectasia: is it associated with myocardial ischaemia and infarction?S J Cross, H S Lee, A C Kenmure, et al.
Scottish Medical Journal|April 1, 1989
Long-term prognosis after resuscitation from primary ventricular fibrillation complicating acute transmural myocardial infarction in the north east of ScotlandN S Chan, M Hughes, N A Irvine, et al.
Cardiovascular Research|October 1, 1971
Effects of oxygen on myocardial blood flow and metabolismA C Kenmure, J M Beatson, A J Cameron, et al.
American Heart Journal|September 1, 1970
Pacemaker lifetimes--a review and definitions, based on experience in Glasgow with Chardack-Greatbatch (medtronic) pacemakersG D Green, W Forbes, W H Bain, et al.
European Heart Journal|July 1, 1990
Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarctionJ M Rawles, M J Metcalfe, C Shirreffs, et al.
Lancet (London, England)|October 27, 1973
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarctionC Warlow, G Terry, A C Kenmure, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Heart Journal|February 1, 1987
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxideN S Chan, J McLay, A C Kenmure
British Medical Journal|June 3, 1978
Cardiac signs for students: the wheat and the chaffJ K Finlayson, A C Kenmure, D S Short
American Heart Journal|February 1, 1972
A four-year review of cardiac pacing in Glasgow: 181 Medtronic generators implanted in 127 patientsG D Green, W Forbes, G B Shaw, et al.
Journal of Applied Physiology|February 1, 1972
Hemodynamic effects of oxygen at 1 and 2 Ata pressure in healthy subjectsA C Kenmure, W R Murdoch, I Hutton, et al.
Scottish Medical Journal|February 1, 1993
Coronary artery ectasia: is it associated with myocardial ischaemia and infarction?S J Cross, H S Lee, A C Kenmure, et al.
Scottish Medical Journal|April 1, 1989
Long-term prognosis after resuscitation from primary ventricular fibrillation complicating acute transmural myocardial infarction in the north east of ScotlandN S Chan, M Hughes, N A Irvine, et al.
Cardiovascular Research|October 1, 1971
Effects of oxygen on myocardial blood flow and metabolismA C Kenmure, J M Beatson, A J Cameron, et al.
American Heart Journal|September 1, 1970
Pacemaker lifetimes--a review and definitions, based on experience in Glasgow with Chardack-Greatbatch (medtronic) pacemakersG D Green, W Forbes, W H Bain, et al.
European Heart Journal|July 1, 1990
Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarctionJ M Rawles, M J Metcalfe, C Shirreffs, et al.
Lancet (London, England)|October 27, 1973
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarctionC Warlow, G Terry, A C Kenmure, et al.
Pageof 3